141 related articles for article (PubMed ID: 37975786)
1. Microstructural and functional alterations of the ventral pallidum are associated with levodopa-induced dyskinesia in Parkinson's disease.
Gan Y; Su D; Zhang Z; Zhang Z; Yan R; Liu Z; Wang Z; Zhou J; Lam JST; Wu T; Jing J; Feng T
Eur J Neurol; 2024 Feb; 31(2):e16147. PubMed ID: 37975786
[TBL] [Abstract][Full Text] [Related]
2. Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia.
Su D; Gan Y; Zhang Z; Cui Y; Zhang Z; Liu Z; Wang Z; Zhou J; Sossi V; Stoessl AJ; Wu T; Jing J; Feng T
Mov Disord; 2023 Apr; 38(4):616-625. PubMed ID: 36799459
[TBL] [Abstract][Full Text] [Related]
3. Altered functional connectivity of cerebellar dentate nucleus in peak-dose dyskinesia in Parkinson's disease.
Zhang H; Wang L; Gan C; Cao X; Ji M; Sun H; Yuan Y; Zhang K
Front Aging Neurosci; 2022; 14():943179. PubMed ID: 36034152
[TBL] [Abstract][Full Text] [Related]
4. Cerebellar connectivity in Parkinson's disease with levodopa-induced dyskinesia.
Yoo HS; Choi YH; Chung SJ; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
Ann Clin Transl Neurol; 2019 Nov; 6(11):2251-2260. PubMed ID: 31643140
[TBL] [Abstract][Full Text] [Related]
5. Contracted thalamic shape is associated with early development of levodopa-induced dyskinesia in Parkinson's disease.
Yoo HS; Lee EC; Chung SJ; Ye BS; Sohn YH; Seong JK; Lee PH
Sci Rep; 2022 Jul; 12(1):12631. PubMed ID: 35879381
[TBL] [Abstract][Full Text] [Related]
6.
Sun HM; Wang LN; Ji M; Gan CT; Yuan YS; Cao XY; Zhang H; Zhang KZ
Quant Imaging Med Surg; 2022 Jun; 12(6):3264-3275. PubMed ID: 35655818
[TBL] [Abstract][Full Text] [Related]
7. The increased gray matter volumes of precentral gyri in Parkinson's disease patients with diphasic dyskinesia.
Zhi Y; Wang M; Yuan YS; Shen YT; Ma KW; Gan CT; Si QQ; Wang LN; Cao SW; Zhang KZ
Aging (Albany NY); 2019 Nov; 11(21):9661-9671. PubMed ID: 31699957
[TBL] [Abstract][Full Text] [Related]
8. Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease.
Hong JY; Oh JS; Lee I; Sunwoo MK; Ham JH; Lee JE; Sohn YH; Kim JS; Lee PH
Neurology; 2014 May; 82(18):1597-604. PubMed ID: 24719485
[TBL] [Abstract][Full Text] [Related]
9. Resting-state connectivity predicts levodopa-induced dyskinesias in Parkinson's disease.
Herz DM; Haagensen BN; Nielsen SH; Madsen KH; Løkkegaard A; Siebner HR
Mov Disord; 2016 Apr; 31(4):521-9. PubMed ID: 26954295
[TBL] [Abstract][Full Text] [Related]
10. Altered brain structural topological properties in Parkinson's disease with levodopa-induced dyskinesias.
Wang L; Wang M; Si Q; Yuan Y; Ma K; Gan C; Zhang K
Parkinsonism Relat Disord; 2019 Oct; 67():36-41. PubMed ID: 31621605
[TBL] [Abstract][Full Text] [Related]
11. Altered dynamic functional network connectivity in levodopa-induced dyskinesia of Parkinson's disease.
Si Q; Gan C; Zhang H; Cao X; Sun H; Wang M; Wang L; Yuan Y; Zhang K
CNS Neurosci Ther; 2023 Jan; 29(1):192-201. PubMed ID: 36229900
[TBL] [Abstract][Full Text] [Related]
12. Prefrontal alterations in Parkinson's disease with levodopa-induced dyskinesia during fMRI motor task.
Cerasa A; Pugliese P; Messina D; Morelli M; Gioia MC; Salsone M; Novellino F; Nicoletti G; Arabia G; Quattrone A
Mov Disord; 2012 Mar; 27(3):364-71. PubMed ID: 22076870
[TBL] [Abstract][Full Text] [Related]
13. Levodopa-induced dyskinesia is preceded by increased levels of anxiety and motor impairment in Parkinson's disease patients.
Dias CMV; Leal DAB; Brys I
Int J Neurosci; 2023 Dec; 133(12):1319-1325. PubMed ID: 35603453
[No Abstract] [Full Text] [Related]
14. Impulse Control Disorders and Levodopa-Induced Dyskinesias in Parkinson's Disease: Pulsatile versus Continuous Dopaminergic Stimulation.
Simoni S; Paoletti FP; Eusebi P; Cappelletti G; Filidei M; Brahimi E; Nigro P; Santangelo V; Parnetti L; Calabresi P; Tambasco N
J Parkinsons Dis; 2020; 10(3):927-934. PubMed ID: 32280105
[TBL] [Abstract][Full Text] [Related]
15. Different functional connectivity modes of the right fronto-insular cortex in akinetic-rigid and tremor-dominant Parkinson's disease.
Wang J; Shen Y; Peng J; Wang A; Wu X; Chen X; Liu J; Wei M; Zou D; Han Y; Cheng O
Neurol Sci; 2021 Jul; 42(7):2937-2946. PubMed ID: 33236247
[TBL] [Abstract][Full Text] [Related]
16. Levodopa-induced dyskinesia in Parkinson's disease: epidemiology, etiology, and treatment.
Zesiewicz TA; Sullivan KL; Hauser RA
Curr Neurol Neurosci Rep; 2007 Jul; 7(4):302-10. PubMed ID: 17618536
[TBL] [Abstract][Full Text] [Related]
17. Levodopa improved different motor symptoms in patients with Parkinson's disease by reducing the functional connectivity of specific thalamic subregions.
Liu W; Shen Y; Zhong Y; Sun Y; Yang J; Zhang W; Yan L; Liu W; Yu M
CNS Neurosci Ther; 2024 Feb; 30(2):e14354. PubMed ID: 37452488
[TBL] [Abstract][Full Text] [Related]
18. Association of dopamine receptor D3 polymorphism with Levodopa-induced Dyskinesia: A study on Parkinson's disease patients from India.
Sarkar S; Biswas A; Ansari S; Choudhury S; Banerjee R; Chatterjee S; Dey S; Kumar H
Neurosci Lett; 2024 Mar; 825():137706. PubMed ID: 38431040
[TBL] [Abstract][Full Text] [Related]
19. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S
Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
[TBL] [Abstract][Full Text] [Related]
20. Altered functional connectivity of the marginal division in Parkinson's disease with mild cognitive impairment: A pilot resting-state fMRI study.
Li MG; Chen YY; Chen ZY; Feng J; Liu MY; Lou X; Shu SY; Wang ZF; Ma L
J Magn Reson Imaging; 2019 Jul; 50(1):183-192. PubMed ID: 30644620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
